结论:(1)PGL的DLBCL组和MALT组的18F-FDG PET/CT表现有差异,DLBCL组代谢参数高于MALT组,更易发生胃窦受累,多部位受累,胃壁弥漫性增厚,胃周浸润,胃腔肿块,胃壁僵硬和淋巴结浸润.SUVmax,TLG,胃壁厚度对于鉴别MALT与DLBCL更有临床意义,其中SUVmax作为DLBCL与MALT的鉴别指标显示了较高的诊断效能.(2)LDH,分期,NCCN-...
P058 Modified NHL-BFM-90 program in primary gastric diffuse large B-cell lymphoma (PGDLBCL) with adverse prognostic factorsP058 Modified NHL-BFM-90 program in primary gastric diffuse large B-cell lymphoma (PGDLBCL) with adverse prognostic factorsp058 modified nhl-bfm-90 program in primary gastri...
H5 and the m6A-binding protein IGF2BP2 are involved in the malignant progression of DLBCL, and that the cardiotonic drug ouabain can inhibit the proliferation of DLBCL cells by inhibiting the expression of ALKBH5 and IGF2BP2, which provides new insights into the targeted treatment of DLBCL....
原发中枢神经系统DLBCL描述正确的有:()。 A.指原发于颅内或眼内的DLBCL,也包括硬脑膜淋巴瘤、血管内大B细胞淋巴瘤、淋巴瘤继发中枢神经系统受侵及免疫缺陷相关淋巴瘤 B.原发中枢神经系统DLBCL不足NHL的1%,占原发脑肿瘤的2%～3%。中位发病年龄约为60岁,男性略多于女性 C.原发中枢神经系统DLBCL的血管周围浸润更...
GPX4 knockdown reversed doxorubicin resistance in TCFL5-overexpressed DLBCL cells. Conclusion: DLBCL cells overexpress TCFL5 that promotes chemoresistance by regulating GPX4. Targeting TCFL5 may provide a prospective therapeutic strategy for doxorubicin-resistant DLBCL. 展开 关键词: DLBCL Doxorubicin Drug ...